MedAvail Holdings, Inc (MDVL)

Market Cap	42.43M
Revenue (ttm)	39.04M
Net Income (ttm)	-49.17M
Shares Out	80.05M
EPS (ttm)	-1.45
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	127,431
Open	0.5
Previous Close	0.53
Day's Range	0.464 - 0.534
52-Week Range	0.45 - 3.56
Beta	-1.21
Analysts	Buy
Price Target	4.59 (+835.4%)
Earnings Date	Nov 14, 2022

About MDVL

MedAvail Holdings, Inc., a technology-enabled retail pharmacy technology and services company, develops and commercializes self-service pharmacy, mobile application, kiosk, and drive-thru solutions in the United States and Canada. It operates in two segments, Retail Pharmacy Services and Pharmacy Technology. The company's MedCenter enables on-site pharmacy in medical clinics, retail store locations, employer sites with and without onsite clinics, and other location where onsite prescription dispensing is desired, as well as establishes an audio...

• Industry: Pharmaceutical Retailers
• CEO: Joseph Mannello
• Employees: 287
• Stock Exchange: NASDAQ
• Ticker Symbol: MDVL

Full Company Profile

Financial Performance

In 2021, MDVL's revenue was $22.13 million, an increase of 58.43% compared to the previous year's $13.97 million. Losses were -$43.82 million, 63.4% more than in 2020.

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for MDVL stock is "Buy." The 12-month stock price forecast is 4.59, which is an increase of 835.40% from the latest price.

Price Target

$4.59

(835.40% upside)

Analyst Consensus: Buy

Stock Forecasts